HCW Biologics and Akron Biotech partner to commercialize HCW11-006 for enhanced CAR-T cell therapy manufacturing.

Veru announces sabizabulin's potential as a treatment for daraxonrasib-resistant pancreatic cancer, supported by new ...

New translational biomarker data from the Phase 2a GRI-0621-IPF-02 study support a unique profile for GRI-0621 among ...

Can-Fite BioPharma reports clinical progress in cancer and psoriasis therapies, alongside H1 2026 financial outcomes.

EVI Industries (EVI) reported record fiscal fourth-quarter revenue of $121.9 million for the quarter ended June 30, 2026, up ...

Worthington Enterprises Inc. will discuss Q1 earnings on September 23, accessible via webcast and phone.

GE Aerospace plans to acquire Consolidated Precision Products for $11.75 billion to enhance casting capacity and meet strong ...

AGM Group and HashBeaver collaborate to create a desktop node for decentralized networks, enhancing Bitcoin mining and ...

Yale University approved the initiation of patient recruitment for Parts B and C of Clearmind's Phase I/II clinical trial ...

Dyne Therapeutics will present one-year clinical data from the Phase 1/2 ACHIEVE trial at prestigious international ...

Artiva Biotherapeutics announced expected clinical data updates and a Phase 3 trial initiation for AlloNK in refractory RA by ...

3 E Network outlines its AI storage initiatives, focusing on integrated hardware solutions for improved data processing ...